Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
NCT00573547
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Principal Investigator decided not to initiate the study.
Conditions
Depression
Interventions
DRUG:
Fluoxetine
Sponsor
Creighton University